Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avi Ashkenazi

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
Current Pain and Headache Reports|July 10, 2009
The role of botulinum neurotoxin in pain management--an ongoing controversyAvi Ashkenazi
Nature Reviews. Cancer|August 22, 2002
Targeting death and decoy receptors of the tumour-necrosis factor superfamilyAvi Ashkenazi
Nature Reviews. Drug Discovery|November 8, 2008
Directing cancer cells to self-destruct with pro-apoptotic receptor agonistsAvi Ashkenazi
Current Pain and Headache Reports|April 29, 2010
Allodynia in cluster headacheAvi Ashkenazi
Current Neurology and Neuroscience Reports|April 29, 2010
Botulinum toxin type a for chronic migraineAvi Ashkenazi
Cytokine & Growth Factor Reviews|May 23, 2008
Targeting the extrinsic apoptosis pathway in cancerAvi Ashkenazi
The Journal of Clinical Investigation|February 3, 2015
Targeting the extrinsic apoptotic pathway in cancer: lessons learned and future directionsAvi Ashkenazi
Cytokine & Growth Factor Reviews|June 6, 2003
Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapyAlexandru Almasan, Avi Ashkenazi
Archives of Neurology|January 16, 2008
Botulinum toxin type A for the treatment of headache: why we say yesAvi Ashkenazi, Stephen Silberstein
Postgraduate Medicine|October 6, 2004
Three common neuralgias. How to manage trigeminal, occipital, and postherpetic painAvi Ashkenazi, Morris Levin
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
Current Pain and Headache Reports|July 10, 2009
The role of botulinum neurotoxin in pain management--an ongoing controversyAvi Ashkenazi
Nature Reviews. Cancer|August 22, 2002
Targeting death and decoy receptors of the tumour-necrosis factor superfamilyAvi Ashkenazi
Nature Reviews. Drug Discovery|November 8, 2008
Directing cancer cells to self-destruct with pro-apoptotic receptor agonistsAvi Ashkenazi
Current Pain and Headache Reports|April 29, 2010
Allodynia in cluster headacheAvi Ashkenazi
Current Neurology and Neuroscience Reports|April 29, 2010
Botulinum toxin type a for chronic migraineAvi Ashkenazi
Cytokine & Growth Factor Reviews|May 23, 2008
Targeting the extrinsic apoptosis pathway in cancerAvi Ashkenazi
The Journal of Clinical Investigation|February 3, 2015
Targeting the extrinsic apoptotic pathway in cancer: lessons learned and future directionsAvi Ashkenazi
Cytokine & Growth Factor Reviews|June 6, 2003
Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapyAlexandru Almasan, Avi Ashkenazi
Archives of Neurology|January 16, 2008
Botulinum toxin type A for the treatment of headache: why we say yesAvi Ashkenazi, Stephen Silberstein
Postgraduate Medicine|October 6, 2004
Three common neuralgias. How to manage trigeminal, occipital, and postherpetic painAvi Ashkenazi, Morris Levin
Pageof 14